SEROLOGICALS CORP
10-Q, EX-27, 2000-08-09
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: SEROLOGICALS CORP, 10-Q, EX-10.27, 2000-08-09
Next: DAVIDSON INCOME REAL ESTATE LP, 10QSB, 2000-08-09



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF SEROLOGICAL CORPORATION FOR THE SIX MONTHS ENDED JUNE
25, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             DEC-27-1999
<PERIOD-END>                               JUN-25-2000
<CASH>                                           2,136
<SECURITIES>                                         0
<RECEIVABLES>                                   25,640
<ALLOWANCES>                                         0
<INVENTORY>                                     31,245
<CURRENT-ASSETS>                                64,828
<PP&E>                                          48,727
<DEPRECIATION>                                  16,020
<TOTAL-ASSETS>                                 146,550
<CURRENT-LIABILITIES>                           17,249
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           259
<OTHER-SE>                                     108,147
<TOTAL-LIABILITY-AND-EQUITY>                   146,550
<SALES>                                         78,232
<TOTAL-REVENUES>                                78,232
<CGS>                                           56,320
<TOTAL-COSTS>                                   56,320
<OTHER-EXPENSES>                                14,186
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 886
<INCOME-PRETAX>                                  6,840
<INCOME-TAX>                                     2,462
<INCOME-CONTINUING>                              4,378
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,378
<EPS-BASIC>                                       0.19
<EPS-DILUTED>                                     0.19


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission